XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 74,745 $ 426,124
Total current assets 74,745 426,124
Land (Note 3) 5,233,204 5,233,204
Other receivable 154,622 154,622
Other assets 200,080 80
Total assets 5,662,651 5,814,030
Current liabilities:    
Convertible notes and line of credit payable (Note 5) 1,962,500 1,962,500
Debenture payable (Note 6) 50,000 50,000
Convertible debenture payable (Note 6) 1,800,000 1,800,000
Short term notes and interest bearing advance (Note 7) 65,504 65,504
Total current liabilities 19,471,680 18,676,733
Total liabilities 19,471,680 18,676,733
Commitments and contingencies (Notes 3 and 12)
Stockholders’ deficit:    
Preferred stock, $0.01 par value; shares authorized 5,000,000, outstanding 2,086,000 at June 30, 2024 and December 31, 2023 (aggregate liquidation preference of $2,519,080 at June 30, 2024 and December 31, 2023) 20,860 20,860
Common stock, $0.001 par value; shares authorized 50,000,000, issued: 39,052,472 at June 30, 2024 and December 31, 2023 outstanding: 36,297,576 at June 30, 2024 and December 31, 2023 39,052 39,052
Additional paid-in capital 36,687,991 36,663,780
Unearned ESOP shares (2,490,662) (2,490,662)
Accumulated deficit (47,833,339) (46,862,802)
Treasury stock, at cost, 1,084,431 shares at June 30, 2024 and December 31, 2023 (232,931) (232,931)
Total stockholders’ deficit (13,809,029) (12,862,703)
Total liabilities and stockholders’ deficit 5,662,651 5,814,030
Related Party [Member]    
Current liabilities:    
Accounts payable and accrued expenses 8,705,147 8,315,187
Notes payable 698,601 669,279
Others [Member]    
Current liabilities:    
Accounts payable and accrued expenses 5,634,552 5,272,524
Notes payable $ 555,376 $ 541,739